andrew huberman bpc 157 tb500 Schulz Reacts: Neuroscientist Dr Huberman
Description
Legal Notice and Usage Disclaimer For Research Use Only: BPC-157 is intended strictly for laboratory research and scientific studies
Once-daily subcutaneous injection, titrated from ~200 mcg to ~1,000 mcg/day over roughly 10 weeks
to psychosis and personality changes
Additionally, a 2025 retrospective study on chronic knee pain showed that 14 out of 16 patients reported significant relief lasting 612 months, and a 2024 pilot study on interstitial cystitis achieved symptom resolution in 10 out of 12 subjects
Adding 3 mL creates a 5 mg/mL concentration
Now, granted anecdotal stories, but definitely very interesting
